Effects of arginine vasopressin on differentiation of cardiac fibroblasts into myofibroblasts

Journal of Cardiovascular Pharmacology

Volumn 55, Issue 5, 2010, Pages 489-495

  Yan Hong, Fan ^a   Hui, Dong ^a   Qing, Pan ^a   Lei, Shang ^b   Hai Chang, Wang ^a   Wei, Zhang ^c   Yan Jie, Cao ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Xijing Hospital ^*  (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Arginine vasopressin; Cardiac fibroblasts; Myofibroblasts; Transforming growth factor 1; V1a receptor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ARGIPRESSIN; ARGIPRESSIN RECEPTOR; COLLAGEN; RECEPTOR BLOCKING AGENT; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CELL TRANSFORMATION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FIBROBLAST CULTURE; HEART MUSCLE CELL; IMMUNOFLUORESCENCE; MYOFIBROBLAST; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ACTINS; ANIMALS; ANIMALS, NEWBORN; ARGININE VASOPRESSIN; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77953017540     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181d706ae     Document Type: Article

References (39)

1. Sun Y, Zhang JQ, Zhang J, et al. Cardiac remodeling by fibrous tissue after infarction in rats. J Lab Clin Med. 2000;135:316-323.
2. Janicki JS, Brower GL. The role of myocardial fibrillar collagen in ventricular remodeling and function. J Card Fail. 2002; 8 (Suppl 6) : S319-S225.
3. Caulfield JB, Janicki JS. Structure and function of myocardial fibrillar collagen. Technol Health Care. 1997;5:95-113.
4. Weber KT. Fibrosis in hypertensive heart disease: focus on cardiac fibroblasts. J Hypertens. 2004;22:47-50.
5. Sun Y, Kiani MF, Postlethwaite AE, et al. Infarct scar as living tissue. Basic Res Cardiol. 2002;97:343-347.
6. Teunissen BE, Smeets PJ, Willemsen PH, et al. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts. Cardiovasc Res. 2007;75:519-529.
7. Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther. 2009;123:255-278.
8. Yang XD, Zhao LY, Zheng QS, et al. Effects of arginine vasopressin on growth of rat cardiac fibroblasts: role of V1 receptor. J Cardiovasc Pharmacol. 2003;42:132-135.
9. Price JF, Towbin JA, Denfield SW, et al. Arginine vasopressin levels are elevated and correlate with functional status in infants and children with congestive heart failure. Circulation. 2004;109:2550-2553.
10. Goldsmith SR, Francis GS, Cowley AW Jr, et al. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol. 1983;1:1385-1390.
11. Hupf H, Grimm D, Riegger GA, et al. Evidence for a vasopressin system in the rat heart. Circ Res. 1999;84:365-370.
12. Lijnen P, Petrov V, Rumilla K, et al. Transforming growth factor-beta 1 promotes contraction of collagen gel by cardiac fibroblasts through their differentiation into myofibroblasts. Methods Find Exp Clin Pharmacol. 2003;25:79-86.
13. Lijnen P, Petrov V. Transforming growth factor-beta 1-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts. Methods Find Exp Clin Pharmacol. 2002;24:333-344. (Pubitemid 34857097)
14. Petrov VV, van Pelt JF, Vermeesch JR, et al. TGF-beta1-induced cardiac myofibroblasts are nonproliferating functional cells carrying DNA damages. Exp Cell Res. 2008;314:1480-1494.
15. Gao X, He X, Luo B, et al. Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts. Eur J Pharmacol. 2009;606:115-120.
16. Ruwhof C, van Wamel AE, Egas JM, et al. Cyclic stretch induces the release of growth promoting factors from cultured neonatal cardiomyocytes and cardiac fibroblasts. Mol Cell Biochem. 2000;208:89-98.
17. Li PF, Dietz R, von Harsdorf R. Superoxide induces apoptosis in cardiomyocytes, but proliferation and expression of transforming growth factor-beta1 in cardiac fibroblasts. FEBS Lett. 1999;448:206-210.
18. Zhao W, Zhao T, Chen Y, et al. Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats. Mol Cell Biochem. 2008;317:43-50.
19. Kuwahara F, Kai H, Tokuda K, et al. Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation. 2002;106:130-135.
20. Roy S, Khanna S, Bickerstaff AA, et al. Oxygen sensing by primary cardiac fibroblasts: a key role of p21 (Waf1/Cip1/Sdi1). Circ Res. 2003;92:264-271.
21. Doering CW, Jalil JE, Janicki JS, et al. Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res. 1988t; 22:686-695.
22. Sabbah HN, Sharov VG, Lesch M, et al. Progression of heart failure: a role for interstitial fibrosis. Mol Cell Biochem. 1995;147:29-34.
23. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83:1849-1865.
24. Wang J, Chen H, Seth A, et al. Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts. Am J Physiol Heart Circ Physiol. 2003; 285: H1871-H1881.
25. Masur SK, Dewal HS, Dinh TT, et al. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci U S A. 1996;93:4219-4223.
26. Swaney JS, Roth DM, Olson ER, et al. Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. Proc Natl Acad Sci U S A. 2005;102:437-442.
27. Petrov VV, Fagard RH, Lijnen PJ. Transforming growth factor-beta (1) induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts. J Renin Angiotensin Aldosterone Syst. 2000;1:342-352.
28. Desmouliére A, Rubbia-Brandt L, Grau G, et al. Heparin induces alphasmooth muscle actin expression in cultured fibroblasts and in granulation tissue myofibroblasts. Lab Invest. 1992;67:716-726.
29. Desmouliére A, Rubbia-Brandt L, Abdiu A, et al. Alpha-smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by gamma-interferon. Exp Cell Res. 1992;201:64-73.
30. He YP, Zhao LY, Zheng QS, et al. Involvement of ERK and AKT signaling in the growth effect of arginine vasopressin on adult rat cardiac fibroblast and the modulation by simvastatin. Mol Cell Biochem. 2008;317:33-41.
31. Góźdź A, Szczepańska-Sadowska E, Szczepańska K, et al. Vasopressin V1a, V1b and V2 receptors mRNA in the kidney and heart of the renin transgenic TGR (mRen2) 27 and Sprague Dawley rats. J Physiol Pharmacol. 2002;53:349-357.
32. Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res. 2004;63:423-432.
33. Chao HH, Chen JJ, Chen CH, et al. Inhibition of angiotensin II induced endothelin-1 gene expression by 17-beta-oestradiol in rat cardiac fibroblasts. Heart. 2005;91:664-669.
34. Kupfahl C, Pink D, Friedrich K, et al. Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart. Cardiovasc Res. 2000;46:463-475.
35. Garat C, Van Putten V, Refaat ZA, et al. Induction of smooth muscle alpha-actin in vascular smooth muscle cells by arginine vasopressin is mediated by c-Jun. amino-terminal kinases and p38 mitogen-activated protein kinase. J Biol Chem. 2000;275:22537-22543.
36. Wang J, Seth A, McCulloch CA. Force regulates smooth muscle actin in cardiac fibroblasts. Am J Physiol Heart Circ Physiol. 2000; 279: H2776-H2785.
37. Flaumenhaft R, Abe M, Mignatti P, et al. Basic fibroblast growth factorinduced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity. J Cell Biol. 1992;118:901-909.
38. Prowse CV, Douglas JG, Forrest JA, et al. Haemostatic effects of lysine vasopressin and triglycyl lysine vasopressin infusion in patients with cirrhosis. Eur J Clin Invest. 1980;10:49-54.
39. Mannucci PM. Enhancement of plasminogen activator by vasopressin and adrenaline: a role of cyclic AMP? Thromb Res. 1974;4:539-549.